FDA Inspection 1110711 — Mayne Pharma International PTY LTD

Mayne Pharma International PTY LTD — FEI 3004090027

The FDA completed an inspection of Mayne Pharma International PTY LTD on October 18, 2019 in Salisbury South. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 18, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salisbury South (Australia)